Although significant progress has been made in the design of blood-compatible polymers in the past decades, there is no ideal polymer surface which is comparable with a natural endothelial surface in preventing surface-induced thrombosis and maintaining hemostasis. This is due to the complex pattern of protein and cellular interactions with foreign surfaces, which still demands defining a proven hypothesis to develop non-thrombogenic surfaces. Synthesis of new polymers with optimal mechanical properties and the in vitro and in vivo characterization of these surfaces will require many more years of work. In this article, the surface modification of existing medical polymers for the improvement of blood compatibility is introduced. Surface immobilizing of heparin onto polyurethane, coatings of a polyurethane-poly(ethylene oxide)-heparin graft copolymer, and a coating of thermosensitive polymers on polyurethane will be discussed. All modified surfaces demonstrated superior blood compatibility both in vitro and in vivo. The biological response of these designed systems in vitro, ex vivo and in vivo should provide state-of-the-art materials for the specific application of controlling thrombosis and solving biocompatibility problems.

Keywords:
Heparinized surfaces, Poly(ethylene oxide)- heparin-grafted polyurethane, Thermosensitive polymers
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.